Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02639507 · ClinicalTrials.gov registry record
International Consortium Investigating Early Vitrectomy in Diabetic Macular Edema Patients
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 40
- Enrollment target
NCT02639507: Completed study, sponsored by Mayo Clinic.
NCT02639507 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02639507 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The purpose of this research is to evaluate the effectiveness of vitrectomy for the treatment of diabetic macular edema. Diabetes is known to cause retinal blood vessels to leak, leading to swelling of the central retina (macula), and decreased vision. Removing the vitreous gel with vitrectomy surgery is known to decrease the swelling caused by diabetes. Diabetic retinopathy is often treated with laser or injections of medicine in to the eye.
Interventions
- PROCEDURE Vitrectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-06 |
| Est. Completion | 2020-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02639507
The ClinicalTrials.gov registry entry for NCT02639507 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitrectomy is the first listed.
NCT02639507 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02639507 about?
NCT02639507 is a clinical study titled "International Consortium Investigating Early Vitrectomy in Diabetic Macular Edema Patients". The purpose of this research is to evaluate the effectiveness of vitrectomy for the treatment of diabetic macular edema. Diabetes is known to cause retinal blood vessels to leak, leading to swelling of the central retina (macula), and decreased vision. Removing the vitreous gel with vitrectomy surge...
What is the current status of trial NCT02639507?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2015-06. Estimated completion is 2020-03.
What interventions are being tested in trial NCT02639507?
The interventions under investigation include: Vitrectomy (PROCEDURE).
Who is sponsoring clinical trial NCT02639507?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.